1. Home
2. Resources
3. Knowledge Center
4. Literatures

Literatures

All ReviewsLiteratureProtocol

Safety and Pharmacokinetic Studies of IMMU-132

A Two-Step Immunocapture Assay for ADCs Characterization

Development and Evaluation of Targeting-CDCP1 ADCs

Development and Evaluation of MMAE-Trastuzumab ADCs

Development and Evaluation of PNU-159682 ADCs

Development and Evaluation of Uncialamycin-Based ADCs

Characterization of Ring-Opening Reaction of Succinimide Linker in ADCs Based on Imaging Capillary Isoelectric Focusing (iCIEF)

Development and Validation of ELISA for the Quantification of MMAE-Conjugated ADCs and Total Antibodies

Development and Evaluation of an Anti-CD22-Seco-CBI-Dimer ADC for the Treatment of NHL

Optimizing Lysosomal Activation of ADCs Using Novel Cleavable Dipeptide Linkers

The Feasibility Study of Legumain-Cleavable Linkers for the Efficient and Selective Activation of ADCs with KSPi Payloads

Clinical Toxicity of ADC: A Meta-Analysis of Payloads

Development and Evaluation of Farletuzumab-[Mal-PEG2-Val-Cit-pAB-Eribulin] ADCs (MORAb-202)

Development and Evaluation of Calicheamicin-Based ABBV-011 ADCs for Small Cell Lung Cancer

Clinical Trials Analysis of TROP-2-Directed ADC for NSCLC

Assessment of Reagents for Selenocysteine Conjugation and the Stability of Selenocysteine Adducts

For Research Use Only. NOT FOR CLINICAL USE.